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AB STR ACT  
Objective: To evaluate the antioxidant and antiproliferative effect of methanolic bee pollen extract (BPE) of Malaysian 
stingless bee [Lepidotrigona terminata (L. terminata)] and its synergistic effect with cisplatin (a chemotherapeutic 
drug) on MCF-7 cancer cell line. 
Methods: The antioxidant activity of BPE from L. terminata was measured by using 1,1-diphenyl-2-picrylhydrazyl 
radical (DPPH) assay. Antiproliferative activity at different concentrations of BPE and cisplatin was determined 
through using MTT assay on MCF-7 and L929 cell lines. An interaction effect (synergistic, additive and antagonistic) 
between BPE and cisplatin was determined by CompuSyn software based on MTT assay data. 
Results: The EC50 (50% decrement of DPPH inhibition) of BPE was 0.5 mg/mL. L. terminata BPE exhibited 
antiproliferative activity on both cancer and normal cell lines. The IC50 (concentration of drug that was required for 50% 
of cell inhibition in vitro) of BPE on MCF-7 was 15 mg/mL whereas in normal cell line L929 was 26 mg/mL. The IC50 
for cisplatin on MCF-7 was 20 µmol/L. The combination effect of BPE and cisplatin on MCF-7 cells showed that BPE 
at 15 mg/mL was able to potentiate the inhibitory effect of cisplatin at all different concentrations (2.5–20.0 mg/mL). 
The average of cancer cells inhibition which was potentiated by BPE was around 50%. A combination index values of 
less than 1 reported in the CompuSyn software further proved the synergistic effect between BPE and cisplatin, 
suggesting that BPE was working synergistically with cisplatin.  
Conclusions: Our study therefore suggested that BPE of Malaysian stingless bee, L. terminata is a potential 
chemopreventive agent and can be used as a supplementary treatment for chemotherapy drugs. BPE might be able to 
be used to potentiate the effect of chemotherapy drugs with the possibility to reduce the required dose of the drugs. 
The molecular mechanisms of how the BPE exerts antiproliferative activity will be a much interesting area to look for 
in future studies. 
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1. Introduction
 
   Bee pollen is considered as a functional food due to its compositions of carbohydrates, proteins, amino acids, lipids, 
sugars, fibres, vitamins and mineral salts[1,2]. It is a collection of pollen grains collected by the bees from various 
botanical sources, mixed with nectar and secretion from the hypopharyngeal glands such as β-glycosidase enzymes. 
Its beneficial effect on health is due to the presence of phenolic compounds with high antioxidant activities[1,3].  
   Oxidative damage and carcinogenesis may gradually lead to the formation of tumors through several mechanisms. 
Polyphenols present in bee pollen and other bee products contain antioxidant and antiproliferative activities that can 
regulate cell proliferation and induce apoptosis[4]. Bee pollen has the antioxidative capacity and the ability to 
neutralize active oxygen species, extensively due to the action of polyphenols combination. Previous studies have 
demonstrated that bee pollen can inhibit tumor growth and alleviate the pain of chemotherapy in cancer patients[5,6].  
   In China, bee pollen of Brassica campestris L. (B. campestris) has been widely used as food supplement to 
strengthen body resistance against cancer[7]. A steroid fraction of bee pollen chloroform extract of B. campestris was 
shown to strongly induce apoptosis in human prostate cancer PC-3 cells[7]. A study by Izuta et al. showed that bee 
pollen was able to suppress cells proliferation in in vitro model of vascular endothelial growth factor-induced human 
umbilical vein endothelial cells proliferation and migration[8]. Constituents of bee pollen such as polysaccharides 
were also shown by Wang et al. to have significant antiproliferative activity in colon cancer cell lines[5]. Thus the aim 
of the study is to evaluate the antiproliferative activity of bee pollen extract (BPE) from Malaysian stingless bee, 
Lepidotrigona terminata (L. terminata) and its effect when combined with cisplatin on MCF-7 cancer cell lines. 
 
2. Materials and methods 
 
2.1. Samples and reagents 
 
   Bee pollen or bee bread sample was acquired from a local stingless bee company, K.B meliponini. The source of 
bee pollen was from the species of L. terminata. The species was identified by the Entomology Section, Malaysian 
Agriculture and Research Development Institute, Serdang, Malaysia. Bee pollen sample was dried at 37 °C for two 
consecutive days and once dried, was kept at 4 °C until further use. 
 
2.2. Bee pollen crude extract  
 
   The crude BPE was prepared by using modified method from LeBlanc et al. by extracting 10 g of bee pollen in 25 
mL of 100% methanol[9]. The mixture was vortexed for 10 min and sonicated for 1 h at 41 °C before kept overnight at 
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4 °C. The mixture was then centrifuged at 6 000 r/min for 10 min and the precipitation was discarded. The supernatant 
was filtered by using a 0.2 µm sterile filter unit (Millipore, USA). Once filtered, it was dried in the rotary evaporator at 
41 °C and freeze dried. The freeze dried BPE was kept at 4 °C until further analysis. 
 
2.3. Antioxidant activity 
 
   The free radical-scavenging capacity of bee pollen methanolic extract was determined by its ability to bleach the 
stable 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and was expressed as the percentage of its neutralization. A 
modification of a method reported by Baharum et al. was employed[10]. The reaction mixture contained 150 µL of 
DPPH (600 µmol/L) with 7.5 µL of different concentrations of BPEs (3.125, 6.250, 12.500, 25.000, 50.000 and 
100.000 mg/mL). The final concentrations of bee pollen were 0.15, 0.30, 0.60, 1.20, 2.40 and 4.80 mg/mL. After 30 
min at room temperature, the reaction mixture was measured by the absorbance at λ = 517 nm. Trolox, a water-
soluble derivative of vitamin E at concentration of 25–600 µmol/L, was used as standard. DPPH free radical 
scavenging activity was calculated through using the following formula: 
% Scavenging = (Absorbance of control - Absorbance of test sample/Absorbance of control) × 100 
2.4. Cell culture 
   MCF-7 and L929 cell lines used in this study were obtained from the Advanced Medical and Dental Institute, 
Universiti Sains Malaysia. The cell lines were cultured in a complete Dulbecco’s modified Eagle’s medium (DMEM) 
containing 4 mmol/L L-alanyl-glutamine (GlutaMAX™) and supplemented with 10% (v/v) fetal bovine serum, 100 
IU/mL of penicillin and 0.1 mg/mL of streptomycin. The cells were grown in humidified atmosphere under the 
conditions of 37 °C with 5% (v/v) CO2. 
 
2.5. Cell counts 
 
   MCF-7 and L929 cells were harvested by removing the medium, washed with phosphate buffer saline (pH 7.45 
without Ca2+ and Mg2+) and then incubated with 1 mL of 0.25% trypsin for 2 min. The flask was gently tapped to 
detach them from the plastic surface. Five milliliters of medium was added to the cell suspension while the remaining 
cells were vigorously washed from the bottom of the culture vessel. The suspended cells were then collected in a 15 
mL centrifuge tube and an aliquot of 10 µL was taken out prior centrifugation for cell count by using haemocytometer. 
The number of cells per milliliter and the total cell number were calculated. Subsequently after centrifugation, an 
appropriate volume of complete medium was added to the cell pellet. 
 
2.6. Preparation of compound treatments  
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    BPE stock solution (100 mg/mL) was prepared by diluting 0.1 g of crude extracts in 1 mL DMEM. The solution was 
then filtered by using a 0.2 µL sterile filter unit (Millipore, USA) and diluted with culture medium to the final 
concentration of 2.5 mg/mL, 5 mg/mL, 10 mg/mL, 20 mg/mL and 40 mg/mL for treatments.  
    Cisplatin stock solution (10 mol/L) was prepared by dissolving 6 mg of cisplatin (molecular weight = 300.01 
g/moL) in 2 mL DMEM. The stock solution was then diluted with culture medium to the final concentration of 2.5 
µmol/L, 5 µmol/L, 10 µmol/L, 20 µmol/L and 40 µmol/L for treatments. The working solutions of the drug were 
freshly prepared prior usage. 
 
2.7. Cytotoxicity determination by using MTT assay 
 
   Briefly, the cells were seeded at density of 1 × 104 cells per well of flat-bottomed 96-well microplate. The cells were 
incubated at 37 °C in a humidified 5% (v/v) CO2 for 24 h to let the cells attach to the bottom of each well. The 
cultured cells were then treated with different concentrations of BPE and cisplatin, alone and with combination when 
the cells reached 70% confluence.  
   The cells were treated with 5 different concentrations of BPE (2.5, 5.0, 10.0, 20.0 and 40.0 mg/mL) and 5 different 
concentrations of cisplatin (2.5, 5.0, 10.0, 20.0 and 40.0 µmol/L). A total of 200 µL of medium containing compound 
treatments was added into each well. Treatments were carried out in triplicate. Well with only treatment solution 
(either BPE or cisplatin) was used as blank or background control, whereas well containing cells without treatment 
was used as negative control. Once treated, cells were incubated for 48 h. 
   The percentage of cell proliferation was determined by using MTT assay with the Vybrant® MTT cell proliferation 
assay kit (Thermo Fisher Scientific, USA). In brief, the fresh medium was replaced after 48 h of incubation. Ten 
microlitres of the 12 mmol/L MTT stock solution were added into each well. The cells with MTT solution were 
incubated in the CO2 incubator for 4 h. The medium was then removed from the well after the cells were labelled with 
MTT. DMSO (50 µL) was added to each well and mixed thoroughly with a pipette. The plate was incubated again at 
37 °C for 10 min. Finally the absorbance was read at 540 nm. The percentage of cell proliferation was calculated by 
using the formula below: 
% Cell proliferation = (Absorbance sample - Absorbance blank)/ (Absorbance negative control - Absorbance blank) × 
100 
 
2.8. Analysis of synergistic effects 
 
   To determine the synergistic, additive or antagonistic effect, experiment with non-constant combination of BPE and 
cisplatin concentrations was done following the method by Qiao et al. with some modifications[11]. The cells were 
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treated with cisplatin at concentrations of 2.5, 5.0, 10.0, 15.0, 20.0 µmol/L in combination with fixed concentration of 
IC50 of BPE at 15 mg/mL. The data from this experiment were analysed through using CompuSyn software to 
determine the synergistic, additive and antagonistic effect of the drugs combination. The statistical analysis was 
performed and the result was presented as combination index (CI). A CI value is a mathematical and quantitative 
representation of the pharmacological interplay of two drugs (CI > 1: antagonism; CI = 1: additive; CI < 1: 
synergism)[12].  
 
2.9. Statistical analysis 
 
   All values were expressed as the mean ± SD. The differences in the mean of treated and untreated cells were 
analysed by using IBM SPSS Statistics 22 (US). 
 
3. Results  
 
3.1. Antioxidant capacity of BPE 
 
   In this study, the antioxidant activity of methanolic crude extract of L. terminata BPE measured by using DPPH 
assay showed a concentration dependent manner in the dose response curve (Figure 1). The EC50 (50% decrement of 
DPPH inhibition) of BPE was 0.5 mg/mL.  
 
3.2. Antiproliferative effect in vitro  
 
   The potential antiproliferative effect of BPE was assayed by using the surrogate cell viability MTT assay. Crude BPE 
was shown to inhibit the growth of both cancer and normal cell lines. The inhibition of cell growth on the breast 
cancer MCF-7 and normal L929 cell lines by BPE of L. terminata was in dose–dependent manner (Figure 2). The IC50 
of BPE on MCF-7 was 15 mg/mL, whereas in normal cell line was 26 mg/mL. BPE at 20 mg/mL inhibited 70% of cell 
viability in the MCF-7 cells (Figure 2A) whereas in normal L929 cell lines, inhibition of 70% of cell viability was 
observed with much higher concentration of 40 mg/mL (Figure 2B). 
 
3.3. Cytotoxic synergism of BPE with chemotherapy drug 
 
   To determine the combination effect of BPE and cisplatin (an anticancer chemotherapy drug), we have designed a 
non-constant combination treatment of cisplatin and BPE on MCF-7 cells. Serial concentrations of cisplatin were 
combined with the fixed concentration of BPE at 15 mg/mL. Higher MCF-7 cells inhibition was seen in BPE (15 
mg/mL) and cisplatin at all concentrations when compared to cisplatin alone. BPE combination with 2.5 µmol/L 
cisplatin inhibited 55% of MCF-7 cells proliferation when compared with 2.5 µmol/L cisplatin alone. Whereas BPE in 
combination with 20 µmol/L cisplatin could further reduce cell proliferation up to 76% compared to 52% reduction 
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seen in treatment of 20 µmol/L cisplatin alone, although it was not statistically significant. The result showed that the 
BPE was able to potentiate the inhibitory effect of cisplatin in breast cancer cells when combined with cisplatin at all 
concentrations (Figure 3). 
   To further confirm the interaction between cisplatin and BPE, the data was computed in CompuSyn software. CI 
values of less than 1 were seen in all interactions between BPE and cisplatin. Reported results in the CompuSyn 
software were between 0.46 and 0.97 (Table 1). The lowest CI value was seen in combination of BPE and cisplatin at 
10.0 µmol/L dose.  
 
4. Discussion 
 
   Our study showed that the antioxidant activity of L. terminata BPE exhibited much higher percentage of DPPH 
inhibition than other Malaysian stingless bee species reported recently. BPE from species Trigona apicalis and 
Trigona itama at concentration of 1 mg/mL showed 39% and 19% of DPPH inhibition, respectively, compared to 70% 
DPPH inhibition of 1 mg/mL methanolic BPE from L. terminata[13]. However, the result of this study showed lower 
inhibition than that of Silva et al. which reported that crude BPE from the Brazilian stingless bee species Melipona 
rufiventris at concentration 0.1 mg/mL was shown to exhibit 50% DPPH inhibition[14]. 
   The difference in antioxidant activity seen in our study could be due to the difference of the solvent used (methanol 
in this study vs. ethanol in the study by Silva et al.), which may give different compounds extraction efficacy, 
therefore contributed to the different chemical activities[14,15]. Furthermore specific pollen foraging activities, 
different pollen species and different diets of stingless bee itself may give different compounds activities found in 
BPE[14,16]. Previous studies have shown that bee pollen has good antioxidant properties related to the presence of 
phenolic compounds[2,17].  
   The antiproliferative activity of L. terminata BPE against MCF-7 and L929 cell lines was evaluated by using MTT 
assay. The concentration of BPE required to inhibit 50% of MCF-7 cells growth was 15 mg/mL. At 20.0 mg/mL, 70% 
inhibition of MCF-7 cells was seen. Whereas in normal L929 cell line, 26 mg/mL was required to exhibit 50% cells 
inhibition. The response different between normal and cancer cells may suggest that BPE can be relatively safe in 
normal cells and considered to be a useful agent for anticancer application in future. The much lower IC50 of BPE in 
cancer cells suggests that BPE may be specifically targeting the MCF-7 cancer cells. 
   Similar antiproliferative effect of BPE had been reported in the study by Kustiawan et al. by using four stingless bee 
species[18]. The result revealed that all four species were cytotoxic to different cell lines tested although their 
antiproliferative activities were rather low compared to the chemotherapeutic drugs used. Another study by Wu and 
Lou also showed strong antiproliferative activity of B. campestris bee pollen chloroform extract in inducing apoptosis 
in human prostate cancer[7]. The observed cytotoxic activity exhibited by bee pollen varied with the different solvent 
used, bee species and different cell lines. 
   In cytotoxic synergism assay, the average of MCF-7 cells inhibition by BPE in combination of cisplatin was around 
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50%. This study shows that BPE is able to potentiate and enhance the cisplatin effect on MCF-7 cells at all 
concentrations. 
   Active compounds in the BPE might either enhance (synergistic) or decrease (antagonistic) the therapeutic activity 
of chemotherapy drugs. There was a great concern that some compounds present in the natural product might work 
antagonistically instead of synergistically with the therapeutic activity of drugs[19]. In this study, CI values reported in 
all interactions between BPE and cisplatin were less than 1. These CI values further proved the synergistic effect 
between the two compounds.  
   This study may suggest that BPE from Malaysian stingless bee L. terminata can be used to supplement the 
chemotherapeutic agents due to its antiproliferative activitiy and its ability to enhance the effect of chemotherapy 
agent, even at low concentration. In a recent review by Komosinska-Vassev et al., bee pollen supplement can help to 
improve the condition of early prostate cancer when given together with chemotherapeutic drug[20]. Furthermore, bee 
pollen as supplement can be combined with chemotherapy treatment to treat side effects of cancer as reported in a 
recent study by Salles et al. which showed that bee pollen was able to improve muscle mass and metabolism in 
undernourished rats[21]. Decreasing muscle mass and poor metabolisms were commonly seen in patients with 
cancer[22]. The combination of chemotherapy drug and natural product such as BPE may be potentially effective in 
cancer treatment in future.  
   The data of this study suggest that bee pollen extract of Malaysian stingless bee is a potential chemopreventive 
agent and can be used as a supplement during chemotherapy treatment. The same data indicate that BPE works 
synergistically with chemotherapy drug, cisplatin and enhances the effect of cisplatin even at lower concentration. The 
molecular mechanisms of how the BPE exerts its antiproliferative and synergistic activities with cisplatin will be a 
promising area to further explore in future studies. 
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Table 1 
CI data for combination effect of cisplatin and BPE on MCF-7 cells. 
Cisplatin dose (µmol/L) 
 
BPE dose (mg/mL) 
 
Effect 
 
CI 
 
2.5 
 
15.0 
 
0.454 1 
 
0.970 6 
 
5.0 
 
15.0 
 
0.411 5 
 
0.947 2 
 
10.0 
 
15.0 
 
0.289 3 
 
0.463 2 
 
15.0 15.0 0.265 2 0.849 5 
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20.0 
 
15.0 
 
0.236 0 
 
0.905 7 
 
 
 
Figure legends: 
Figure 1. Scavenging effect of methanolic extract from L. terminata BPE at different concentrations (0.15, 0.3, 0.6, 1.2, 2.4 and 
4.8 mg/mL) on the stable DPPH.  
Results were expressed as percentage of DPPH inhibition with respect to control; Each value represents the mean ± SD. 
Figure 2. Antiproliferative effect of BPE at different concentrations on MCF-7 cell lines and L929 cell lines.  
A: MCF-7 cell lines; B: L929 cell lines; Each value represents the mean ± SD from three separate experiments. 
Figure 3. The effect of cisplatin alone and combination of cisplatin and BPE on MCF-7 cells.  
The percentage of cell proliferation was measured at 48 h post-treatment; Each value represents the mean ± SD from three 
separate experiments; Statistical analysis was determined by using Student’s t-test with **: P < 0.001; *: P < 0.05. 
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Figure 1. Scavenging effect of methanolic extract from L. terminata BPE 
at different concentrations (0.15, 0.3, 0.6, 1.2, 2.4 and 4.8 mg/mL) on the 
stable DPPH. 
Results were expressed as percentage of DPPH inhibition with respect to 
control; Each value represents the mean µ SD.
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Figure 2. Antiproliferative effect of BPE at different concentrations on MCF-7 cell lines and L929 cell lines. 
A: MCF-7 cell lines; B: L929 cell lines; Each value represents the mean µ SD from three separate experiments.
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Figure 3. The effect of cisplatin alone and combination of cisplatin and 
BPE on MCF-7 cells. 
The percentage of cell proliferation was measured at 48 h post-treatment; 
Each value represents the mean µ SD from three separate experiments; 
Statistical analysis was determined by using StudentÊs t-test with **: P < 
0.001; *: P < 0.05.
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